LRRK2 and Parkinson disease: The iPSC lines were derived from two LRRK2-PD patients carrying the G2019S mutation (L2-PD), one healthy donor (CTL), and two isogenic iPSC lines in which the LRRK2 G2019S missense mutation was corrected (L2-PDcorr) (Table 1).